This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Medical Ethics  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

J. David Baxter, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with interest the comments made in a recent issue concerning pharmaceutical sales.¹ Undue pressure masked as marketing is inappropriate, but physicians must make decisions concerning new agents based on information given to them by pharmaceutical companies, since the initial studies of new agents are sponsored and paid for by the pharmaceutical companies. When pharmaceutical representatives come into my office with their information, studies, and samples, I am aware that they are sponsored by their company. This is akin to watching a commercial for the product.

In my outpatient practice, the lunches I ate, and will continue to eat as long as it is legal, help me and my office staff with our expenses as well as help us to learn valuable information concerning new products. The samples I receive are invaluable to my patients.

One of my close personal friends runs a business where . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Time for the Medical Profession to Act: New Policies Needed Now on Interactions Between Pharmaceutical Companies and Physicians
Philip Greenland
Arch Intern Med. 2009;169(9):829-831.
EXTRACT | FULL TEXT